DWA
CDNA icon

Dorsey Wright & Associates’s CareDx CDNA Stock Holding History

Dorsey Wright & Associates’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,023
Closed -$32K – 292
2019
Q1 		$32K Sell
1,023
-1,023
-50% -$29.8K 0.01% 128
2018
Q4 		$51K Buy
2,046
+341
+20% +$8.76K 0.02% 108
2018
Q3 		$49K Buy
+1,705
New +$31.9K 0.01% 117

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Dorsey Wright & Associates's CDNA Position: Q2 2019 in Review

Dorsey Wright & Associates sold out of CareDx (CDNA) in Q2 2019, closing a stake of 1,023 shares — an estimated $32K sold.

Dorsey Wright & Associates first reported a position in CDNA in Q3 2018 and held it in 3 quarters. The position peaked at $51K in Q4 2018. 182 funds tracked by Wall St. Rank hold CDNA as of Q2 2019.

  • Dorsey Wright & Associates reported no remaining CareDx position as of Q2 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,023 CareDx shares in Q2 2019, an estimated $32K.
  • Dorsey Wright & Associates first reported a position in CareDx in Q3 2018 and held it in 3 quarters.
  • Dorsey Wright & Associates's CareDx position peaked at $51K in Q4 2018.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q2 2019.

Based on Dorsey Wright & Associates's 13F filing for Q2 2019, filed 2 Jul 2019.